These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14668654)

  • 1. Levetiracetam in the treatment of neuropathic pain: three case studies.
    Price MJ
    Clin J Pain; 2004; 20(1):33-6. PubMed ID: 14668654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.
    Dunteman ED
    J Pain Palliat Care Pharmacother; 2005; 19(1):35-43. PubMed ID: 15814513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
    Ardid D; Lamberty Y; Alloui A; Coudore-Civiale MA; Klitgaard H; Eschalier A
    Eur J Pharmacol; 2003 Jul; 473(1):27-33. PubMed ID: 12877934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.
    Falah M; Madsen C; Holbech JV; Sindrup SH
    Eur J Pain; 2012 Jul; 16(6):860-9. PubMed ID: 22337561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable levetiracetam-associated depression in the elderly: two case reports.
    Vande Griend JP; Linnebur SA; Bainbridge JL
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):281-4. PubMed ID: 19948304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin.
    Ragueneau-Majlessi I; Levy RH; Meyerhoff C
    Epilepsy Res; 2001 Nov; 47(1-2):55-63. PubMed ID: 11673021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
    Matías-Guíu J; Molins A; Mauri JA; Villar E
    Methods Find Exp Clin Pharmacol; 2010 Sep; 32(7):507-16. PubMed ID: 21069102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman.
    Foley KT; Bugg KS
    Am J Geriatr Pharmacother; 2010 Apr; 8(2):170-4. PubMed ID: 20439066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
    Frucht SJ; Louis ED; Chuang C; Fahn S
    Neurology; 2001 Sep; 57(6):1112-4. PubMed ID: 11571347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.
    Boon P; Chauvel P; Pohlmann-Eden B; Otoul C; Wroe S
    Epilepsy Res; 2002 Jan; 48(1-2):77-89. PubMed ID: 11823112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
    Holbech JV; Otto M; Bach FW; Jensen TS; Sindrup SH
    Eur J Pain; 2011 Jul; 15(6):608-14. PubMed ID: 21183370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial.
    Navarro V; Dagron C; Elie C; Lamhaut L; Demeret S; Urien S; An K; Bolgert F; Tréluyer JM; Baulac M; Carli P;
    Lancet Neurol; 2016 Jan; 15(1):47-55. PubMed ID: 26627366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
    Morrell MJ; Leppik I; French J; Ferrendelli J; Han J; Magnus L
    Epilepsy Res; 2003 May; 54(2-3):153-61. PubMed ID: 12837566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam efficacy in refractory partial-onset seizures, especially after failed epilepsy surgery.
    Motamedi M; Nguyen DK; Zaatreh M; Singh SP; Westerveld M; Thompson JL; Mattson R; Blumenfeld H; Novotny E; Spencer SS
    Epilepsia; 2003 Feb; 44(2):211-4. PubMed ID: 12558576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdose with levetiracetam: a case report and review of the literature.
    Larkin TM; Cohen-Oram AN; Catalano G; Catalano MC
    J Clin Pharm Ther; 2013 Feb; 38(1):68-70. PubMed ID: 22725831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.